{
    "clinical_study": {
        "@rank": "45112", 
        "arm_group": [
            {
                "arm_group_label": "Placebo control", 
                "description": "Diet pills of 400 mcg of acid folic daily"
            }, 
            {
                "arm_group_label": "D-chiro-inositol / Myo-inositol", 
                "description": "Diet sachets 2000 mg myo-inositol and 250 mg d-chiro-inositol and 400 mcg folic acid daily"
            }, 
            {
                "arm_group_label": "D-chiro-inositol", 
                "description": "Diet pills with 500 mg d-chiro-inositol and 400 mcg folic acid daily"
            }, 
            {
                "arm_group_label": "Myo-inositol", 
                "description": "Diet sachets with 2000 mg myo-inositol and 200 mcg folic acid twice daily"
            }
        ], 
        "brief_summary": {
            "textblock": "Comparison of different inositol stereoisomears in preventing adverse obstetric outcomes in\n      non-obese pregnant women at high risk for gestational diabetes mellitus."
        }, 
        "brief_title": "Myo-inositol, D-chiro-inositol, and D-chiro/Myo-inositol in Gestational Diabetes", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "GDM", 
        "condition_browse": {
            "mesh_term": "Diabetes, Gestational"
        }, 
        "detailed_description": {
            "textblock": "The investigators compared outcomes from metabolic and obstetric point of view in GDM\n      pregnant non-obese patient with different stereoisomears of inositol supply. Dietary control\n      and placebo or inositol steroisomears were administered starting at the enrolling time\n      (first fasting oral glucose above 92 mg%; usually before 20 weeks gestations') till the\n      delivery and/or pregnancy end/termination. Oral glucose tolerance test results at 24-28\n      weeks' gestation was evaluated (as glucose values and oGTT screening). Fetal growth,\n      delivery data, obstetric outcomes and necessity of insulin therapy were taken into account."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  pregnancy below 20 weeks gestation BMI below 30 Fasting glucose between 92 and 126\n             mg% Singleton pregnancy Naturally conceived\n\n        Exclusion Criteria:\n\n          -  obese patient Fasti g glucose above 126 or below 92"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "Non obese pregnant women during first trimester of pregnancy with scared fasting glucose\n        (above 92 mg%)"
            }
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01762826", 
            "org_study_id": "INOS002"
        }, 
        "intervention": [
            {
                "arm_group_label": "Myo-inositol", 
                "description": "Dietary control plus Myo-inositol", 
                "intervention_name": "Myo-inositol", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "Supplementation of myo-inositol plus dietary control"
            }, 
            {
                "arm_group_label": "D-chiro-inositol", 
                "description": "Dietary control plus D-Chiro-Inositol supplementation", 
                "intervention_name": "D-chiro-inositol", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "D-chiro-inositol / Myo-inositol", 
                "description": "Dietary control Supplementation with myo and d-chiro inositol", 
                "intervention_name": "D-Chiro / Myo-inositol", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "Placebo control", 
                "description": "Dietary control plus folic acid 400 mcg daily", 
                "intervention_name": "Placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Inositol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Inositol", 
            "GDM"
        ], 
        "lastchanged_date": "January 4, 2013", 
        "number_of_groups": "4", 
        "official_title": "Adverse Obstetric Outcomes in Gestational Diabetes Mellitus and Inositol Stereoisomears", 
        "overall_official": [
            {
                "affiliation": "ObGyn Dept University of Chieti", 
                "last_name": "Claudio Celentano, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "ObGyn Dept Univ of Chieti", 
                "last_name": "Barbara Matarrelli, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Diabetology Dept Univ of Chieti", 
                "last_name": "Ester Vitacolonna, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "OGTT is the mainstay of obstetric outcomes in GDM", 
            "measure": "OGTT result", 
            "safety_issue": "Yes", 
            "time_frame": "24-28 weeks' gestation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01762826"
        }, 
        "responsible_party": {
            "investigator_affiliation": "G. d'Annunzio University", 
            "investigator_full_name": "Claudio Celentano", 
            "investigator_title": "MD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Centiles of fetal measurements and amniotic fluid volume", 
                "measure": "Fetal measurements at third trimester", 
                "safety_issue": "Yes", 
                "time_frame": "28 weeks"
            }, 
            {
                "description": "Gestational age at delivery Route of delivery Fetal gender Fetal weight (grams and centiles) Neonatal hypoglycemia", 
                "measure": "Delivery data", 
                "safety_issue": "Yes", 
                "time_frame": "25-42 weeks gestations'"
            }, 
            {
                "description": "Abortion Preterm delivery Polyhydramnios IUGR Macrosomia Fetal distress Preterm delivery pPROM Neonatal morbility (NICU stay, low glucose levels, etc.) Neonatal mortality Cerebral palsy Route of delivery Dystocia Etc.", 
                "measure": "Adverse obstetric outcome", 
                "safety_issue": "Yes", 
                "time_frame": "from first elevated oral fasting glucose (above 92 mg%) till the end/termination of pregnancy (latter 42 weeks gestation)"
            }
        ], 
        "source": "G. d'Annunzio University", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Chieti", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "G. d'Annunzio University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "September 2012"
    }
}